0000950170-24-066202.txt : 20240529
0000950170-24-066202.hdr.sgml : 20240529
20240529205531
ACCESSION NUMBER: 0000950170-24-066202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THOMAS TOM C
CENTRAL INDEX KEY: 0001239202
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39244
FILM NUMBER: 241000474
MAIL ADDRESS:
STREET 1: 180 LOMA ALTRO
STREET 2: C/O MOCON INC
CITY: LOS GATOS
STATE: CA
ZIP: 95030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vincerx Pharma, Inc.
CENTRAL INDEX KEY: 0001796129
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 833197402
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-800-6676
MAIL ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Vincera Pharma, Inc.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: LifeSci Acquisition Corp.
DATE OF NAME CHANGE: 20191206
4
1
ownership.xml
4
X0508
4
2024-05-23
0001796129
Vincerx Pharma, Inc.
VINC
0001239202
THOMAS TOM C
260 SHERIDAN AVENUE, SUITE 400
PALO ALTO
CA
94306
false
true
false
false
See Remarks
false
Stock Option (right to buy)
7.38
2024-05-23
4
A
false
31250
0.00
A
2034-03-06
Common Stock
31250
125000
D
The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.
General Counsel and Chief Legal Officer
By: /s/ Tom C. Thomas
2024-05-29